Veracyte, Inc. (VCYT) insider trading.
In Q3 2026, insiders at Veracyte, Inc. reported 15 non-derivative transactions on 9 Forms 3, 4 and 5: 0 open-market purchases and 9 sales worth $1.3M.
- Transactions
- 15
- Purchases (P)
- 0
- Sales (S)
- 9
- Net shares, P minus S
- -30,895
- Insiders
- 8
- Last filed
- 2026-09-22
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Febbo Phillip G. | Officer · Chief Scientific & Med Officer | 3 | 0 | 2 |
| Chambers Rebecca | Officer · Chief Financial Officer | 3 | 0 | 2 |
| McGuire Annie | Officer · EVP, General Counsel | 3 | 0 | 2 |
| Leite John | Officer · Global Chief Commercial Off | 2 | 0 | 1 |
| Holstein Jens | Director | 1 | 0 | 1 |
| Stapley Marc | Director, Officer · Chief Executive Officer | 1 | 0 | 0 |
| Wygant Jonathan | Officer · VP, Chief Accounting Officer | 1 | 0 | 0 |
| Bhanji Muna | Director | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-21 | Leite John | S (D) | 4,015 | $40 | 124,329 | Form 4 |
| 2026-09-14 | Holstein Jens | S (D) | 5,000 | $40.95 | 27,471 | Form 4 |
| 2026-09-04 | Febbo Phillip G. | S (D) | 10,405 | $42.89 | 135,753 | Form 4 |
| 2026-09-04 | Febbo Phillip G. | S (D) | 2,705 | $43.66 | 133,048 | Form 4 |
| 2026-09-04 | Chambers Rebecca | S (D) | 1,175 | $43.71 | 166,025 | Form 4 |
| 2026-09-04 | Chambers Rebecca | S (D) | 2,477 | $42.81 | 167,200 | Form 4 |
| 2026-09-04 | McGuire Annie | S (D) | 1,100 | $43.67 | 131,160 | Form 4 |
| 2026-09-04 | McGuire Annie | S (D) | 2,154 | $42.79 | 132,260 | Form 4 |
| 2026-09-02 | Stapley Marc | F (D) | 8,782 | $44.88 | 432,073 | Form 4 |
| 2026-09-02 | Wygant Jonathan | F (D) | 1,361 | $44.88 | 43,226 | Form 4 |
| 2026-09-02 | Febbo Phillip G. | F (D) | 3,639 | $44.88 | 146,158 | Form 4 |
| 2026-09-02 | Chambers Rebecca | F (D) | 3,603 | $44.88 | 169,677 | Form 4 |
| 2026-09-02 | McGuire Annie | F (D) | 3,215 | $44.88 | 134,414 | Form 4 |
| 2026-09-02 | Leite John | F (D) | 3,961 | $44.88 | 128,344 | Form 4 |
| 2026-09-01 | Bhanji Muna | S (D) | 1,864 | $42.97 | 42,718 | Form 4 |
Transaction codes in this quarter
Get VCYT insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1384101&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · VCYT company page · Veracyte, Inc. on SEC.gov
Questions
Are insiders buying or selling Veracyte, Inc. (VCYT)?
In Q3 2026, insiders at Veracyte, Inc. reported 15 non-derivative transactions on 9 Forms 3, 4 and 5: 0 open-market purchases and 9 sales worth $1.3M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Veracyte, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/vcyt.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.